Fri, Jul 25, 2014, 3:42 AM EDT - U.S. Markets open in 5 hrs 48 mins


% | $
Click the to save as a favorite.

Antares Pharma Inc. Message Board

  • pure_savvy pure_savvy Dec 28, 2012 9:08 AM Flag

    Do not pay ZACKS any attention

    For the past almost two years that I have been associated with Antares, I have witnessed ZACKS miss their calls constanatly with their STRONG SELL ratings on the stock. I just emailed them and asked kindly if they could please share what the reasoning is for this action under the circumstances that we have many upgrades from very well known investing institutions and that we have products about to explode on the market. That question in itself probably stumped them as I see no reason to keep pounding on the table that you need to SELL...unless "they" want to BUY!

    Everyone try to stay calm as the seas might get a little rough these last couple of trading days. I know a lot you are dissapointed with share price and were expecting a lot higher number. Maybe 2013 will be our year.

    As always Good Luck To You All!


    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • there are many firms that put out technical analysis -
      some try to be honest in their reports - some have
      less than honest motives - for example, representing
      longs or shorts and gearing their analysis to meet their

      I believe good technical analysis is a decent predictor
      in the very short term, and OK for traders, if they can
      do their own work - perhaps assisted by some good and
      honest service.

      But these firms no little or nothing of the fundamental
      value of a company and their tools are only good for short
      term traders.

      If I am investing in a company - to build a large position-
      for a long term hold (so long as the company performs) and
      in anticipation of a very large gain - I don't care if I pay
      a few nickels or dimes - more or less for the stock. I have
      seen too many times that waiting for a cheaper entry point
      causes people to miss great investments by the stock getting
      away from them. Penny Wise and Pound Foolish.

      For investors wanting to trade - technical analysis is fine-
      and maybe Zack's is OK -- and maybe not. I personally have
      no respect for them.

      BUT for the ATRSers here, and elsewhere- I would suggest
      they not pay any attention to such reports.


      Sentiment: Strong Buy

    • Actually, it isn't just Zacks. I regularly check out the Jaywalk Consensus as part of any buy or sell decision, and if I believed Jaywalk, I would be running screaming from ATRS.

      There are only five analysts who Jaywalk tracks that are following ATRS, which is low. Usually there are 10 - 20 for a typical stock. Two have a "hold" rating; two a "sell" and one a "strong sell." The aggregate rating puts ATRS in the bottom 1.5% of the stocks Jaywalk covers.

      That's a rating I would expect for a dying company that is running out of cash, or is way overpriced.

      If I look at the analysts that Yahoo tracks and I look at what I see from my on-line broker, I see significant revenue growth next year coupled with a very modest profit. The EPS for 2014 is puny, but 2015 looks good (49 cents EPS).

      I am well ahead on my position and am in no mood to take profits and "wait and see" on the sidelines.

      So, I sold Feb covered calls at 15 cents for an annualized rate of 16%. I plan on holding and selling calls until I perceive a potential for significant movement, and then I'll stop selling the calls.

      I can envision a couple of scenarios where we could see significant upside movement in 2013, but as hard as I try I can't see any downside risk that would justify a "strong sell" rating


      Sentiment: Buy

2.10-0.08(-3.67%)Jul 24 3:59 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.